Parenteral Packaging Market Size & Share 2025 - 2034

Parenteral Packaging Market Size

The global parenteral packaging market was valued at USD 25.6 billion in 2024 and is estimated to grow at a CAGR of 6.1% from 2025 to 2034. One of the most important factors boosting the market is the high demand for ready-to-use (RTU) solutions. These solutions offer several other advantages, including lower production costs, reduced chances of battery and contamination, and improved stability of the drug.

The use of RTU packaging is on the rise, especially in the pharmaceutical industry where the injectable drug market is growing in leaps and bounds, particularly for oncology drugs which need high-value, sterile packaging. RTU solutions improve manufacturing productivity by eliminating the need for washing, sterilizing, and dehydrogenating empty vials and other containers. This eliminates the need for additional time to produce the injectable and makes it the best solution for pharmaceutical manufacturers as they get greater business value while ensuring their customers get the parenteral drugs they want faster.
 

For instance, in March 2022, SGD Pharma and Stevanato Group launched a 100ml Ready-to-use (RTU) glass vial parenteral vial. Made of molded type 1 glass, this new RTU vial provides sustained drug stability and low particle generation, as well as streamlined processes that reduce the time it takes products to reach the market, particularly injectable devices and other high-value oncological drugs.
 

Parenteral Packaging Market Trends

Parenteral packaging trends show preference toward the use of prefilled syringes, which is due to patient demand regarding safety and precision in drug delivery. This trend has aided the parenteral packaging industry in developing more tools toward comfort, precision, and improved consumer satisfaction. Self-administered devices have revolutionized outpatient and homecare where patients are required to use the equipment without the assistance of a healthcare professional, further eliminating the chances of improper self-medication or errors during medicine preparation. Managing chronic conditions requires adhering to a consistent treatment plan, and self-filled syringes have consistently proven to increase the compliance of such regimens.
 

Parenteral Packaging Market Analysis

Advanced structural packaging is a significant hurdle for the parenteral services market, despite the increasing demand for prefilled syringes, autoinjectors, and complex drug delivery systems. Manufacturers face increasing costs due to advanced materials, specialized manufacturing processes, and stringent quality control regulations. High-quality polymers and glass are needed for these packaging, affecting raw material costs. Engineering, sterilization, and automation for these models require significant resources. As demand continues to grow, firms are urged to comply with regulations at reasonable prices, ensuring compliance with regulations.
 

One opportunity that is still beginning to take shape in the parenteral packaging market is the increasing need for biologics and personalized medicine, which needs a specific type of packaging. The pharmaceutical industry is moving toward biologics, for instance, monoclonal antibodies and gene therapies. There is already a large investment by commercial companies for advanced packaging that can ensure the stability, safety, and efficacy of these sensitive drugs during storage and delivery. This development leads us to a greater opportunity for the new era of parenteral packaging, which includes intelligent packaging systems embedded with a range of sensors to track temperature, humidity, and other conditions which may affect the quality of drugs. Companies that specialize in making affordable, market-friendly, tailor-made biologics as well as secure packaging for such drugs have greater chances of increasing their market share in this evolving business segment.
 

Based on product type, the market is divided into vials & ampoules, cartridges, prefilled syringes, infusion solutions bottles & bags, blister packs, and others. The prefilled syringes segment is expected to reach a value of over USD 10 billion by 2034.
 

• There has been an ever-increasing shift in the healthcare sector alongside a growing demand for self-administration, and owing to these factors, the prefilled syringes segment is expected to make key growth in the parenteral segment. The main advantage offered by pre-filled syringes is the reduction of medication errors because the necessary dosage is already in place and cannot be over or under injected. This is very critical for people suffering from chronic conditions as there are many instances of too many people making preparations for injections. Moreover, with the constant evolution within the medical sector, prefilled syringes, in combination with the patient-oriented approach to home medical care, are more favorable for patients who do not want to be treated only in clinics.
   
• Additionally, the proliferation of biologics and monoclonal antibodies therapies that usually require accurate dosages and more sophisticated methods of injection has led to a surge in demand for prefilled syringes. They are an ideal option for biologic products which are injectable and sensitive as they preserve the integrity and sterility of such drugs during storage and handling. The injectable or injectable-based formulations are expected to capture a large share of the global prefillable syringes market as they are safe and effective in today's clinical practice.

Learn more about the key segments shaping this market

Download Free PDF

Based on material type, the market is divided into glass, plastic, paper and paperboard, and others. The glass segment is the fastest growing segment with a CAGR of over 7% between 2025 and 2034.
 

• The glass segment within the parenteral packaging market is expected to record the highest growth within the estimated period. Glass, due to its advantageous features in safety, stability, and sterility of injectable drugs, is turning out to be a preference. Because glass is inert and does not react with pharmaceutical products, this material provides the required protection for sensitive biologics and vaccines storage. Such non-reactivity plays a vital role since it minimizes pollution or any type of chemical deterioration, assuring that the therapeutic effectiveness of the drug remains molecular aspects throughout its life cycle. The rise of glass packaging, in this regard, has stemmed from the continued evolution of bioengineering and allogeneic cellular therapies because of their functioning compatibility with glass.
   
• Moreover, glass containers like vials and ampoules are extensively used in parenteral packaging, which has existed for a long time in the pharmaceutical sector and is on the rise as they provide durability. With the increasing focus on biologics, the injectable economy, and other novel, sensitive drugs, the concerns over drug stability continue to grow; hence, the glass packaging robust protection aiming to resolve such issues will only seek an increase in demand. Furthermore, glass is a stronger protective barrier against light and moisture, and particular injectable treatments call for it: two important aspects to keep in mind while developing the injectable market.

North America held the share of over 35% in 2024. The United States is witnessing growth of the parenteral packaging market on account of the demand for biologics coupled with the growth of the pharmaceutical and biotechnology industries, as well as a high priority for advanced drug delivery systems. The United States has a strong healthcare system and is at the forefront of pharmaceutical development, which increases the demand for high-level packaging technology that supports the safety, efficacy, and ease of drug use, especially in biologics and diadic medicine. Furthermore, the United States has a developed regulatory environment that promotes the production of quality and compliant packaging systems. Moreover, the increasing self-administration devices and chronic conditions in the region are additionally responsible for the increase in demand for new parenteral packaging technologies.
 

The parenteral packaging industry is growing in China owing to the huge demand for injectable drugs and biologics as a result of increasing chronic disease prevalence and population growth. Moreover, China's parenteral package injectables market is expected to grow owing to enhancements made to compliance regulations and to the healthcare infrastructure of the country that would, in turn, culminate in domestic manufacturers investing in the development of effective parenteral packages. The other growing factors toward the country's improvement in parenteral package injectables market are the increase in self-administration and home care paraphernalia.
 

India is transiting into one of the largest manufacturers and exporters of pharma products, India's increasing parenteral packaging market follows suit. The increasing number of chronic illnesses translates into a greater patient population, translating into a larger demand for injectable drugs, which in turn raises the need for secure packaging solutions. Owing to the Indian government's policies aimed at boosting healthcare inclusion and extending the reach of pharmaceutical products, there has been a growing desire for better parenteral packaging. The changing drug delivery systems, as well as the biotechnology and biopharmaceutical businesses in India, will also drive the demand for better and more affordable packaging technology of injectables.
 

South Korea is experiencing significant expansion in the parenteral packaging industry due to a flourishing biotechnology and health sector. Increased population age as well as chronic diseases and biologics have increased the demand for sophisticated injectable drug packaging. South Korea's growing trend toward self-administered injectables and several smart packaging technologies have also propelled the sector. In addition, the region's promotion of healthcare and imposing stricter regulations also creates a conducive environment for market growth in the region.
 

Japan is witnessing steady growth in the parenteral packaging market owing to the existing pharmaceutical market, aging population, and demand for modern drug delivery systems. The elderly population suffers from chronic illnesses; therefore, increased injectables usage has driven packaging solutions up. The combination of Japan's efforts toward healthcare innovation with progress in drug delivery systems increases the need for sophisticated parenteral solutions like prefilled syringes and autoinjectors. Also, Japan's strong regulations, as well as focus on patient safety, enhance the growth of the sector.
 

Parenteral Packaging Market Share

The competition within the parenteral packaging industry is predominantly based on distinct characteristics such as innovation, price, quality, and regulatory compliance. The companies have been able to sustain their services differently by extending the range of their product's functionalities, which include pre-filled syringes, smart auto injectors, and intelligent smart packaging integrated with sensors. Price competition is still important, especially for those manufacturers working in highly competitive cost economies. Moreover, strong distribution channels and partnering with pharmaceutical manufacturers play an important role in gaining market share as well. Companies also spend on R&D in order to comply with the changing regulatory requirements as well as cater to the market of growing biologics and personalized medicines.
 

Parenteral Packaging Market Companies

Major players operating in the parenteral packaging industry are:

• Adelphi Group
• Amcor
• AptarGroup
• Baxter International
• Berry Global
• Catalent
• Datwyler
• Gerresheimer
• Nipro
• Oliver Healthcare Packaging
• Schott
• SGD Pharma
• Stevanato Group
• Tekni-Plex
• West Pharmaceutical Services
• WestRock
   

Parenteral Packaging Industry News

• In October 2023, SGD Pharma launched Sterinity's Ready-To-Use (RTU) molded glass vials in 10ml and 20ml size. These, with the addition of 10ml and 20ml sterile vials, enable customers Lyo or wide mouth fillable vials. The vials serve pharmaceutical and biopharmaceutical contract manufacturers, compounding pharmacists, hospitals, and veterinary clinics. The complete Sterinity portfolio includes 10, 20, 50, and 100 ml bottles and 20, 25, and 50 EasyLyo vials. High-quality solutions for multiple applications are provided by this broad product range.
   
• In October 2023, ZACROS, a Japanese company, unveiled MediTect flexible packaging technology for parenteral drugs sensitive to the PDA Universe of Pre-Filled Syringes and Injection Devices Conference. IV bag platform MediTect lowers the chances of human mistake and exposure by providing a closed system. Thin films mixed with PE and PP, which imitate glass properties, protect small molecules and biologics.
   

This parenteral packaging market research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue (USD Billion) & volume (Kilo Tons) from 2021 to 2034, for the following segments:

Click here to Buy Section of this Report

Market, By Material Type

• Glass
• Plastic
• Paper and paperboard
• Others

Market, By Product Type

• Vials & ampoules
• Cartridges
• Prefilled syringes
• Infusion solutions bottles & bags
• Blister packs
• Others

Market, By Packaging Type

• Primary packaging
• Secondary packaging
• Tertiary packaging

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Russia
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia 
• Latin America
  • Brazil
  • Mexico 
• MEA
  • UAE
  • Saudi Arabia
  • South Africa